Clinical trial
Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation
NCT05461612 is registered in ClinicalTrials.gov with Maxwell Biomedical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation
- Lead sponsor
- Maxwell Biomedical
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 23, 2022
- Completion date
- December 31, 2023
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.